Assignment #9 Sweetener

“LONDON (AFX) - Renewed concerns over the security of the patents protecting Tate &
Lyle PLC’s lucrative artificial sweetener Sucralose saw the British food producer’s shares
reversing earlier gains today.
The slide came after the FoodNavigator website reported Bangalore, India-based drug-
maker Pharmed Medicare had expressed confidence it had developed an alternative means of
producing the sweetener using a process that would not infringe Tate’s patents. ‘This is the most
serious threat to Sucralose yet seen. I don’t think it’s a death knell, but there’s no doubt this is a
serious threat,’ said Investec analyst David Laing.
A spokeswoman for the British company insisted the 32 patents protecting the product
offered adequate protection.
Pharmed Medicare president Sundeep Aurora, who said the company had taken legal
advice in the United States, Asia and Europe, appeared to admit as much.
He reportedly said the company had yet to develop a means of producing the sweetener
on an economically viable scale. “

ANSWER:

Yes, Pharma Medicare has applied for a patent for their new process. The details below
are the proof and information about the patent Pharma Medicare has applied for the new process
of their sweetener.

Title: REDUCED CALORIE SWEETENER COMPOSITION

Publication Number: WO/2006/027796
Publication Date:16.03.2006
Inventors: RATNAM, Rakesh
AURORA, Suneet
ZANNONI, Joseph, M.

Abstract:
A sweetener composition is described which augments full benefit of reduced calorific
value associated through use of high intensity sweeteners as dominant sweetness contributors,
and yet avoids problem of loss of favorable organoleptic properties associated with their use by
incorporating sugars and other non-sugar low intensity sweeteners in small but an amount
enough to provide a correction in organoleptic properties.

Also published as:

AU2005281300 IN812/MUM/2004
EP1791442 IN278/MUMNP/2007
US20090175997